NFKB1 and diabetic kidney disease: The main strength of this study is the finding that, in a large number of STZ diabetic rats followed for 1 year, development of advanced glomerular sclerotic lesions was closely associated with activation of the NF-κB pathway, and was prevented by inhibition of this system, raising the possibility that such a strategy may be useful against human DKD.